| Pathophysiology of cisplatin‐induced acute kidney injury A Ozkok, CL Edelstein BioMed research international 2014 (1), 967826, 2014 | 768 | 2014 |
| Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia M Takir, O Kostek, A Ozkok, OC Elcioglu, A Bakan, A Erek, HH Mutlu, ... Journal of investigative medicine 63 (8), 924-929, 2015 | 186 | 2015 |
| Hepatitis C virus associated glomerulopathies A Ozkok, A Yildiz World journal of gastroenterology: WJG 20 (24), 7544, 2014 | 175 | 2014 |
| Contrast-induced acute kidney injury: a review of practical points S Ozkok, A Ozkok World journal of nephrology 6 (3), 86, 2017 | 170 | 2017 |
| NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI) A Ozkok, K Ravichandran, Q Wang, D Ljubanovic, CL Edelstein Toxicology letters 240 (1), 105-113, 2016 | 110 | 2016 |
| Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients A Ozkok, Y Caliskan, T Sakaci, G Erten, G Karahan, A Ozel, A Unsal, ... Clinical journal of the American Society of Nephrology 7 (6), 965-973, 2012 | 110 | 2012 |
| Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience A Ozkok, TS Akpinar, F Tufan, NA Kanitez, M Uysal, M Guzel, Y Caliskan, ... Clinical and experimental nephrology 17, 345-351, 2013 | 76 | 2013 |
| Cholesterol-embolization syndrome: current perspectives A Ozkok Vascular Health and Risk Management, 209-220, 2019 | 67 | 2019 |
| FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients A Ozkok, C Kekik, GE Karahan, T Sakaci, A Ozel, A Unsal, A Yildiz BMC nephrology 14, 1-7, 2013 | 63 | 2013 |
| Predicting the outcome of COVID-19 infection in kidney transplant recipients OA Oto, S Ozturk, K Turgutalp, M Arici, N Alpay, O Merhametsiz, S Sipahi, ... BMC nephrology 22, 1-16, 2021 | 57 | 2021 |
| An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease K Ravichandran, I Zafar, A Ozkok, CL Edelstein Nephrology Dialysis Transplantation 30 (1), 45-53, 2015 | 49 | 2015 |
| Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor A Ozkok, A Kanbay, AR Odabas, A Covic, M Kanbay Clinical and Experimental Hypertension 36 (4), 211-216, 2014 | 45 | 2014 |
| Hyperuricemia is associated with progression of IgA nephropathy A Bakan, A Oral, OC Elcioglu, M Takir, O Kostek, A Ozkok, S Basci, ... International urology and nephrology 47, 673-678, 2015 | 43 | 2015 |
| Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review OC Elcioglu, A Ozkok, TS Akpınar, F Tufan, M Sezer, S Umman, ... International journal of hematology 96, 370-375, 2012 | 43 | 2012 |
| Coronary artery calcification and coronary flow velocity in haemodialysis patients Y Caliskan, M Demirturk, A Ozkok, B Yelken, T Sakaci, H Oflaz, A Unsal, ... Nephrology Dialysis Transplantation 25 (8), 2685-2690, 2010 | 41 | 2010 |
| Acute renal infarction in Turkey: a review of 121 cases N Eren, O Gungor, I Kocyigit, FB Guzel, E Erken, O Altunoren, E Tatar, ... International Urology and Nephrology 50, 2067-2072, 2018 | 40 | 2018 |
| CD4 T cell knockout does not protect against kidney injury and worsens cancer K Ravichandran, Q Wang, A Ozkok, A Jani, H Li, Z He, D Ljubanovic, ... Journal of molecular medicine 94, 443-455, 2016 | 40 | 2016 |
| Endothelial progenitor cells and kidney diseases A Ozkok, A Yildiz Kidney and Blood Pressure Research 43 (3), 701-718, 2018 | 37 | 2018 |
| The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury HJ Kim, K Ravichandran, A Ozkok, Q Wang, Z He, A Jani, D Ljubanovic, ... Journal of Pharmacology and Experimental Therapeutics 349 (3), 518-525, 2014 | 37 | 2014 |
| Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2 K Ravichandran, A Ozkok, Q Wang, AE Mullick, CL Edelstein American Journal of Physiology-Renal Physiology 308 (4), F349-F357, 2015 | 35 | 2015 |
kameswaran ravichandranUniversity of colorado denverΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ucdenver.edu
